This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Randall R. Ketchem: Innovator in Therapeutic Molecules
Introduction
Randall R. Ketchem is an accomplished inventor based in Snohomish, WA (US). He currently works at Amgen Inc., a leading biotechnology company. Although he has not yet been granted any patents, his contributions to the field of therapeutic molecules are noteworthy.
Latest Patent Applications
Randall's latest patent applications include innovative projects such as Fc-Containing Molecules Exhibiting Predictable, Consistent, and Reproducible Glycoform Profiles. This invention relates to variant Fc-containing molecules, including antibodies and Fc-fusion molecules, which possess glycosylation characteristics favorable for large-scale production of therapeutic molecules. Another significant application is for GITR Antigen Binding Proteins, which are designed to activate GITR. These antigen binding proteins have potential therapeutic applications, particularly in immunotherapy treatments for various cancers and infections.
Conclusion
Randall R. Ketchem is a dedicated inventor whose work at Amgen Inc. focuses on advancing therapeutic technologies. His latest patent applications reflect his commitment to innovation in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile